Ftse Mib
33.674,33
1,37%
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
NASDAQ
17.721,59
-0,79%
Bitcoin
65.001,72
0,05%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avalo Therapeutics Inc (AVTX) Avalo Therapeutics Inc (AVTX) Notizie

Avalo Therapeutics Inc

AVTX
13,26
1,46 (12,37%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:43:28
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/6/202413:30GLOBEAvalo to Present at the Oppenheimer Novel Targets in..
07/6/202413:01EDGAR2Form PRE 14A - Other preliminary proxy statements
06/6/202422:03EDGAR2Form S-3 - Registration statement under Securities Act of..
03/6/202413:20EDGAR2Form 8-K/A - Current report: [Amend]
23/5/202422:01EDGAR2Form 8-K - Current report
13/5/202418:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/5/202413:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:30EDGAR2Form 8-K - Current report
13/5/202413:30GLOBEAvalo Reports First Quarter 2024 Financial Results and..
02/4/202413:00GLOBEAvalo Therapeutics Appoints Biotech Leaders to Board of..
29/3/202421:01GLOBEAvalo Reports 2023 Financial Results and Provides Business..
27/3/202421:01GLOBEAvalo Acquires Anti-IL-1β mAb and Announces Private..
15/2/202403:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202416:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:01EDGAR2Form 8-K - Current report
28/12/202323:05EDGAR2Form 8-K - Current report
27/12/202313:00GLOBEAvalo Therapeutics Announces 1-for-240 Reverse Stock Split
21/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:01EDGAR2Form 8-K - Current report
07/12/202313:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202313:01EDGAR2Form 8-K - Current report
07/12/202313:00GLOBEAvalo Encourages Stockholders to Vote FOR the Reverse Stock..
16/11/202313:15EDGAR2Form 8-K - Current report
09/11/202313:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:04EDGAR2Form 8-K - Current report
09/11/202313:00GLOBEAvalo Reports Third Quarter 2023 Financial Results and..
31/10/202312:21EDGAR2Form 8-K - Current report
31/10/202312:00GLOBEAvalo Completes Divestiture of AVTX-800 Series
19/10/202322:15EDGAR2Form ARS - Annual Report to Security Holders
19/10/202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/10/202322:01EDGAR2Form DEF 14A - Other definitive proxy statements
17/10/202322:02EDGAR2Form 8-K - Current report
05/10/202322:02EDGAR2Form PRE 14A - Other preliminary proxy statements
26/9/202313:04EDGAR2Form 8-K - Current report
26/9/202313:00GLOBEAvalo Therapeutics Successfully Eliminates $35 Million Debt..
13/9/202322:03EDGAR2Form 8-K - Current report
13/9/202315:12EDGAR2Form 8-K - Current report
12/9/202313:10EDGAR2Form 8-K - Current report
12/9/202313:00GLOBEAvalo Enters into Agreement to Divest AVTX-800 Series
11/9/202313:22EDGAR2Form 8-K - Current report
06/9/202313:00GLOBEAvalo to Present at the H.C. Wainwright 25th Annual Global..
14/8/202322:23EDGAR2Form 8-K - Current report
08/8/202322:11EDGAR2Form 8-K - Current report
07/8/202323:27EDGAR2Form 8-K - Current report
07/8/202323:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/8/202313:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:01EDGAR2Form 8-K - Current report
03/8/202313:00GLOBEAvalo Reports Second Quarter 2023 Financial Results and..
21/7/202314:25EDGAR2Form 8-K - Current report
Apertura: 11,11 Min: 11,11 Max: 13,26
Chiusura: 11,80

La tua Cronologia

NASDAQ
AVTX
Avalo Therapeutics
COIN
SATOSHIETH
Satoshi Nakamoto
COIN
CHTTTUSD
Chronic Token
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network